Philadelphia Shareholder Megan Grossman to Co-Chair HB Litigation Conferences' Drug & Device Defense Seminar for Third Consecutive Year


Philadelphia, PA
December 13, 2016

Segal McCambridge is pleased to announce that Megan Grossman, Philadelphia Shareholder and Co-Chair of the firm's Life Science, Medical Device and Pharmaceutical Practice Group, will act as co-chair for HB Litigation Conferences’ Drug & Device Defense Conference for the third consecutive year. The Conference, which will take place on December 13, 2016, will be held at the Hub Cira Centre in Philadelphia. 

Ms. Grossman is co-chairing the event with Michelle Hart Yeary, Counsel at Dechert LLP. Segal McCambridge's Walter (Pete) H. Swayze, III, Philadelphia Shareholder and Chair of the General Litigation Group, will also speak at the conference.

This is HB’s third event focused exclusively on defense drug and device litigation. Attendees will gain insight on urgent corporate compliance issues, will learn the latest labeling and marketing regulations and will be updated on important trends in product litigation.

Ms. Grossman serves as counsel to many pharmaceutical and device companies and has extensive experience in general and complex litigation matters. Ms. Grossman is uniquely qualified to represent clients in this area having started her career in the biomedical field.